FDA Inspection
GREFIGREFI – FDA Inspection, Apr 5, 2018
Record Details
This FDA Inspection record concerns GREFI, with an inspection on April 5, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 63befdfa-b892-4a51-a280-f62023950dfc
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1048379
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.47(a)Procedures for all other requirements
- 21 CFR 1271.85(a)Infection with communicable disease agents
Full citation text and observation details available on the Dashboard.
Other FDA inspections of GREFI
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2021 | OAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| October 1, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 31, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for GREFI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.